We sought to investigate the potential of the SARS-CoV-2 RNA fragments identified as novel hTLR7 and/or hTLR8 ligands to activate human immune cells such as macrophages, which are essentially present in all organs, act as key innate immune cells, and play a crucial role in COVID-19-related inflammation (8). The gene discussed is TLR8; the disease is COVID-19.